 |
| |
|
This superparamagnetic oral contrast agent consists of large iron oxide particles, coated with insoluble material. Abdoscan® particles have a mean diameter no less than 300 nm. Gastrointestinal superparamagnetic contrast agents are used for negative bowel enhancement.
Abdoscan® was approved in Europe but was taken off the market in 2000, and all sales stopped by the end of 2002.
Drug Information and Specification
T2*, predominantly negative enhancement
PHARMACOKINETIC
Gastrointestinal
CONCENTRATION
23.4 Fe/200ml
DEVELOPMENT STAGE
Not FDA approved
PRESENTATION
Bags with powder
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
| |
 |
| |
| • Share the entry 'Abdoscan®':    | |
| | |
] and 1 definition [
]
Random Page
top
